Ge
Genprobe (Hologic)
San Diego CAFounded 1987800 employees
Private CapbiotechAcquiredInfectious Disease
Platform: Molecular Dx
Market Cap
N/A
All Drugs
2
Clinical Trials
5
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GEN-5535 | GEN-5535 | Phase 1 | 2 | APOC3 | AML | ||
| Niracilimab | GEN-7895 | Phase 3 | 3 | CD19 | Endometrial CaLN |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (5)